PL3996716T3 - Związki przydatne w leczeniu zakażeń wirusem grypy - Google Patents
Związki przydatne w leczeniu zakażeń wirusem grypyInfo
- Publication number
- PL3996716T3 PL3996716T3 PL20836808.4T PL20836808T PL3996716T3 PL 3996716 T3 PL3996716 T3 PL 3996716T3 PL 20836808 T PL20836808 T PL 20836808T PL 3996716 T3 PL3996716 T3 PL 3996716T3
- Authority
- PL
- Poland
- Prior art keywords
- influenza virus
- compounds useful
- virus infections
- treat influenza
- treat
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D345/00—Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962872998P | 2019-07-11 | 2019-07-11 | |
| US201962944309P | 2019-12-05 | 2019-12-05 | |
| PCT/US2020/041578 WO2021007506A1 (en) | 2019-07-11 | 2020-07-10 | Compounds useful to treat influenza virus infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3996716T3 true PL3996716T3 (pl) | 2026-03-09 |
Family
ID=74115271
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20836808.4T PL3996716T3 (pl) | 2019-07-11 | 2020-07-10 | Związki przydatne w leczeniu zakażeń wirusem grypy |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20220033416A1 (pl) |
| EP (1) | EP3996716B1 (pl) |
| JP (1) | JP7631292B2 (pl) |
| KR (1) | KR102976916B1 (pl) |
| CN (2) | CN114907378A (pl) |
| AU (1) | AU2020310921B2 (pl) |
| BR (1) | BR112022000503A2 (pl) |
| CA (1) | CA3142030A1 (pl) |
| ES (1) | ES3060737T3 (pl) |
| IL (1) | IL289655B2 (pl) |
| MX (1) | MX2022000453A (pl) |
| MY (1) | MY209319A (pl) |
| PH (1) | PH12022550033A1 (pl) |
| PL (1) | PL3996716T3 (pl) |
| TW (1) | TWI841759B (pl) |
| WO (1) | WO2021007506A1 (pl) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240151256A (ko) | 2019-03-22 | 2024-10-17 | 길리애드 사이언시즈, 인코포레이티드 | 가교된 트리시클릭 카르바모일피리돈 화합물 및 그의 제약 용도 |
| BR112022000503A2 (pt) | 2019-07-11 | 2022-06-07 | Nanjing Zhegxiang Pharmaceuticals Co Ltd | Compostos úteis para tratar infecções por vírus influenza |
| CN116390924B (zh) | 2020-09-30 | 2025-11-07 | 吉利德科学公司 | 桥连三环氨基甲酰基吡啶酮化合物及其用途 |
| WO2022148434A1 (zh) * | 2021-01-08 | 2022-07-14 | 辉诺生物医药科技(杭州)有限公司 | 吡啶酮多并环类衍生物及其应用 |
| CR20260070A (es) * | 2021-01-19 | 2026-04-24 | Gilead Sciences Inc | COMPUESTOS DE PIRIDOTRIAZINA SUSTITUIDOS Y USOS DE ESTOS (Divisional 2023-0315) |
| TW202308646A (zh) * | 2021-05-10 | 2023-03-01 | 大陸商南京征祥醫藥有限公司 | 治療流感化合物的晶型及應用 |
| CN114790214B (zh) * | 2021-06-11 | 2024-01-26 | 南京征祥医药有限公司 | 含硒抗流感化合物及其中间体吡啶并三嗪二酮衍生物和二氢二苯并硒平衍生物的制备方法 |
| CN117924284A (zh) * | 2021-11-01 | 2024-04-26 | 南京知和医药科技有限公司 | 一种高效抗病毒化合物及其用途 |
| CN115947737B (zh) * | 2022-01-26 | 2023-11-28 | 南京赛弗斯医药科技有限公司 | 一种含硒化合物及其用途 |
| CN118047795A (zh) * | 2022-03-09 | 2024-05-17 | 南京征祥医药有限公司 | 一种含硒抗流感药物的制备方法 |
| CN119487040A (zh) * | 2022-07-05 | 2025-02-18 | 辉诺生物医药科技(杭州)有限公司 | 吡啶酮多并环类衍生物的晶型及其制备方法 |
| CN117003766B (zh) * | 2022-10-08 | 2024-02-02 | 石家庄迪斯凯威医药科技有限公司 | 一种抗流感病毒衍生物及其用途 |
| WO2024098856A1 (zh) * | 2022-11-09 | 2024-05-16 | 石家庄迪斯凯威医药科技有限公司 | 一种抗流感病毒衍生物及其用途 |
| WO2024098273A1 (zh) * | 2022-11-09 | 2024-05-16 | 石家庄迪斯凯威医药科技有限公司 | 一种抗流感病毒磷酸酯类化合物及其用途 |
| CN118496239B (zh) * | 2023-04-14 | 2026-07-17 | 南京卡文迪许生物工程技术有限公司 | 一种酰乙酯多环化合物及其药物组合物和用途 |
| CN118561867B (zh) * | 2024-05-27 | 2025-04-18 | 安徽贝克制药股份有限公司 | 一种帽状依赖性核酸内切酶抑制剂及其制备方法和其应用 |
| CN119119081A (zh) * | 2024-06-12 | 2024-12-13 | 南京卡文迪许生物工程技术有限公司 | 一种酰乙酯多环化合物的制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107709321A (zh) * | 2015-04-28 | 2018-02-16 | 盐野义制药株式会社 | 经取代的多环性吡啶酮衍生物及其前药 |
| HK1254961A1 (en) * | 2015-12-15 | 2019-08-02 | Shionogi & Co., Ltd. | Medicine for treating influenza characterized by comprising combination of cap-dependent endonuclease inhibitor with anti-influenza drug |
| US10759814B2 (en) * | 2016-08-10 | 2020-09-01 | Shionogi & Co., Ltd. | Pharmaceutical compositions containing substituted polycyclic pyridone derivatives and prodrug thereof |
| EP3686201A4 (en) * | 2017-09-18 | 2021-04-28 | Sunshine Lake Pharma Co., Ltd. | INFLUENCE VIRUS REPLICATION INHIBITOR AND ITS USES |
| CN109503625A (zh) * | 2018-01-19 | 2019-03-22 | 赵蕾 | 一种多环吡啶酮化合物及其药物组合和用途 |
| BR112022000503A2 (pt) | 2019-07-11 | 2022-06-07 | Nanjing Zhegxiang Pharmaceuticals Co Ltd | Compostos úteis para tratar infecções por vírus influenza |
-
2020
- 2020-07-10 BR BR112022000503A patent/BR112022000503A2/pt unknown
- 2020-07-10 WO PCT/US2020/041578 patent/WO2021007506A1/en not_active Ceased
- 2020-07-10 MX MX2022000453A patent/MX2022000453A/es unknown
- 2020-07-10 PL PL20836808.4T patent/PL3996716T3/pl unknown
- 2020-07-10 KR KR1020227004191A patent/KR102976916B1/ko active Active
- 2020-07-10 PH PH1/2022/550033A patent/PH12022550033A1/en unknown
- 2020-07-10 ES ES20836808T patent/ES3060737T3/es active Active
- 2020-07-10 AU AU2020310921A patent/AU2020310921B2/en active Active
- 2020-07-10 EP EP20836808.4A patent/EP3996716B1/en active Active
- 2020-07-10 JP JP2022500920A patent/JP7631292B2/ja active Active
- 2020-07-10 IL IL289655A patent/IL289655B2/en unknown
- 2020-07-10 TW TW109123422A patent/TWI841759B/zh active
- 2020-07-10 US US17/297,407 patent/US20220033416A1/en not_active Abandoned
- 2020-07-10 CN CN202210528727.1A patent/CN114907378A/zh active Pending
- 2020-07-10 MY MYPI2022000138A patent/MY209319A/en unknown
- 2020-07-10 CN CN202080004760.3A patent/CN113226327B/zh active Active
- 2020-07-10 CA CA3142030A patent/CA3142030A1/en active Pending
-
2022
- 2022-01-05 US US17/569,367 patent/US11466029B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022541404A (ja) | 2022-09-26 |
| EP3996716A1 (en) | 2022-05-18 |
| CN114907378A (zh) | 2022-08-16 |
| CN113226327B (zh) | 2022-05-17 |
| JP7631292B2 (ja) | 2025-02-18 |
| IL289655B2 (en) | 2026-03-01 |
| MY209319A (en) | 2025-07-02 |
| KR20220034827A (ko) | 2022-03-18 |
| PH12022550033A1 (en) | 2023-04-03 |
| AU2020310921B2 (en) | 2025-11-13 |
| WO2021007506A1 (en) | 2021-01-14 |
| US20220127282A1 (en) | 2022-04-28 |
| EP3996716C0 (en) | 2025-12-10 |
| TWI841759B (zh) | 2024-05-11 |
| US11466029B2 (en) | 2022-10-11 |
| IL289655B1 (en) | 2025-11-01 |
| CN113226327A (zh) | 2021-08-06 |
| MX2022000453A (es) | 2022-04-18 |
| US20220033416A1 (en) | 2022-02-03 |
| AU2020310921A1 (en) | 2022-02-10 |
| EP3996716A4 (en) | 2023-07-26 |
| TW202118763A (zh) | 2021-05-16 |
| ES3060737T3 (en) | 2026-03-27 |
| BR112022000503A2 (pt) | 2022-06-07 |
| EP3996716B1 (en) | 2025-12-10 |
| IL289655A (en) | 2022-03-01 |
| KR102976916B1 (ko) | 2026-06-11 |
| CA3142030A1 (en) | 2021-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL289655B2 (en) | Compounds useful for treating influenza virus infections | |
| IL263972A (en) | Dihydropyranopyrimidines for the treatment of viral infections | |
| ZA201901430B (en) | Therapeutic compounds useful for the prophylactic or therapeutic treatment of an hiv virus infection | |
| PL3684377T3 (pl) | Sposoby leczenia zakażenia wirusem zapalenia wątroby typu b | |
| ZA201903161B (en) | Antiviral compositions for the treatment of infections linked to coronaviruses | |
| PH12017500207A1 (en) | Indoles for use in influenza virus infection | |
| IL280769A (en) | New sulfonimidylpurinone compounds and their history for the treatment and prevention of virus infection | |
| EA201790571A1 (ru) | Пирролопиримидины для применения при инфекции, вызванной вирусом гриппа | |
| CL2015003615A1 (es) | Nucleósidos sustituidos, nucleótidos y análogos de los mismos. | |
| PH12017501598B1 (en) | Ã-D-2`-DEOXY-2`a-FLUORO-2`-Ã-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR HCV TREATMENT | |
| LT3436074T (lt) | Tiazolido junginiai, skirti virusinių infekcijų gydymui | |
| EA201891278A1 (ru) | Гетероциклические индолы для применения при инфекции, вызванной вирусом гриппа | |
| SI3400225T1 (sl) | Pentanojske kisline substituirane s pirolo-(2-3,b)pirimidin-piridini za zdravljenje okužb z virusom gripe | |
| HK1249046A1 (zh) | 治疗b型肝炎病毒的方法 | |
| HRP20181570T1 (hr) | Režim doziranja spoja fgf-18 | |
| ZA201804025B (en) | Inactivation of viruses by delipidation | |
| DK3471732T3 (da) | Liposomer til behandling af virusinfektioner | |
| IL288713A (en) | Methods for treating viral infections | |
| HK40072924A (en) | Methods to treat viral infections | |
| HK40021231A (en) | Combination therapies for treating influenza virus infection | |
| HK40014101A (zh) | 中和流感病毒的化合物 | |
| HK40009496A (en) | Antiviral compositions for the treatment of infections linked to coronaviruses | |
| HK40006685A (en) | Dihydropyranopyrimidines for the treatment of viral infections | |
| HK1246806A1 (zh) | 中和流感病毒的拟肽化合物 |